What does APOTHEEK MEERDAAL do?

APOTHEEK MEERDAAL is a pharmacy in Oud-Heverlee. Public Limited, started on 30 December 1988, 1 establishment.

What is the address of APOTHEEK MEERDAAL?

The registered office of APOTHEEK MEERDAAL is located at Bierbeekstraat 2B box 1, 3052 Oud-Heverlee.

Is APOTHEEK MEERDAAL still active?

Yes. According to the CBE (31 October 2026) APOTHEEK MEERDAAL is active, legal situation “Normale toestand”, started on 30 December 1988.

Is APOTHEEK MEERDAAL registered on Peppol?

Yes, APOTHEEK MEERDAAL is registered on the Peppol network with ID 0208:0436782387.

What is the enterprise number of APOTHEEK MEERDAAL?

The enterprise number of APOTHEEK MEERDAAL is BE0436782387.

When was APOTHEEK MEERDAAL founded?

APOTHEEK MEERDAAL was founded on 30 December 1988.

Who are the directors of APOTHEEK MEERDAAL?

According to the 2025 annual accounts, the directors of APOTHEEK MEERDAAL are: Fré Pharma BV.

Is APOTHEEK MEERDAAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 December 1988; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK MEERDAAL make in 2025?

APOTHEEK MEERDAAL posted a profit after taxes of € 171,332 in financial year 2025.

What is the revenue of APOTHEEK MEERDAAL?

As a small company, APOTHEEK MEERDAAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 300,429.

How much does an employee at APOTHEEK MEERDAAL earn?

The average wage cost per full-time employee at APOTHEEK MEERDAAL was € 58,200 in 2025: staff costs of € 58,188 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK MEERDAAL have?

According to the 2025 annual accounts, APOTHEEK MEERDAAL has 1 full-time equivalents (FTE).

APOTHEEK MEERDAAL (Public Limited) - Oud-Heverlee

Dossier APOTHEEK MEERDAAL, printed on 31 October 2026 from databakkes.be/en/0436782387/apotheek-meerdaal. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK MEERDAAL from Oud-Heverlee, company number BE0436782387, closed financial year 2025 with a result of € 171,332 after tax. For that financial year APOTHEEK MEERDAAL recorded a gross margin of € 300,429 and equity of € 800,212. Compared with financial year 2024, the result moved from € 96,762 to € 171,332. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.

What it is worth Growing

€ 800,212

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 171,332

▲ 77% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 208,960

▲ 88% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 150,000 paid out

88 % of the profit went to the shareholders, mostly to Fré Pharma (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 58,188

▲ 4% vs 2024

€ 58,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 371,166

▼ 5% vs 2024

€ 21,938 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 102,829

▲ 8% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 9,872

▲ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 203,854 Gross margin 2022: € 203,854 First fiscal year in the series	€ 227,216 Gross margin 2023: € 227,216 ▲ 11% vs 2022 (€ 203,854) Favourable step	€ 226,885 Gross margin 2024: € 226,885 Unchanged (€ 227,216) Unfavourable step	€ 300,429 Gross margin 2025: € 300,429 ▲ 32% vs 2024 (€ 226,885) Favourable step	▲ 32%
Profit after taxes	€ 104,425 Profit after taxes 2022: € 104,425 First fiscal year in the series	€ 103,934 Profit after taxes 2023: € 103,934 Unchanged (€ 104,425) Unfavourable step	€ 96,762 Profit after taxes 2024: € 96,762 ▼ 7% vs 2023 (€ 103,934) Unfavourable step	€ 171,332 Profit after taxes 2025: € 171,332 ▲ 77% vs 2024 (€ 96,762) Favourable step	▲ 77%
Equity	€ 673,183 Equity 2022: € 673,183 First fiscal year in the series	€ 757,118 Equity 2023: € 757,118 ▲ 12% vs 2022 (€ 673,183) Favourable step	€ 778,880 Equity 2024: € 778,880 ▲ 3% vs 2023 (€ 757,118) Favourable step	€ 800,212 Equity 2025: € 800,212 ▲ 3% vs 2024 (€ 778,880) Favourable step	▲ 3%
Total debts	€ 541,741 Total debts 2022: € 541,741 First fiscal year in the series	€ 503,364 Total debts 2023: € 503,364 ▼ 7% vs 2022 (€ 541,741) Favourable step	€ 577,452 Total debts 2024: € 577,452 ▲ 15% vs 2023 (€ 503,364) Unfavourable step	€ 638,051 Total debts 2025: € 638,051 ▲ 10% vs 2024 (€ 577,452) Unfavourable step	▲ 10%
Cash	€ 143,160 Cash 2022: € 143,160 First fiscal year in the series	€ 83,326 Cash 2023: € 83,326 ▼ 42% vs 2022 (€ 143,160) Unfavourable step	€ 111,372 Cash 2024: € 111,372 ▲ 34% vs 2023 (€ 83,326) Favourable step	€ 208,960 Cash 2025: € 208,960 ▲ 88% vs 2024 (€ 111,372) Favourable step	▲ 88%
Land & buildings	€ 651,809 Land & buildings 2022: € 651,809 First fiscal year in the series	€ 616,404 Land & buildings 2023: € 616,404 ▼ 5% vs 2022 (€ 651,809) Unchanged	€ 589,857 Land & buildings 2024: € 589,857 ▼ 4% vs 2023 (€ 616,404) Unchanged	€ 553,440 Land & buildings 2025: € 553,440 ▼ 6% vs 2024 (€ 589,857) Unchanged	▼ 6%
Retained profit	€ 478,183 Retained profit 2022: € 478,183 First fiscal year in the series	€ 562,118 Retained profit 2023: € 562,118 ▲ 18% vs 2022 (€ 478,183) Favourable step	€ 583,880 Retained profit 2024: € 583,880 ▲ 4% vs 2023 (€ 562,118) Favourable step	€ 605,212 Retained profit 2025: € 605,212 ▲ 4% vs 2024 (€ 583,880) Favourable step	▲ 4%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 20,000 Dividend 2023: € 20,000 Unchanged (€ 0) Unchanged	€ 75,000 Dividend 2024: € 75,000 ▲ 275% vs 2023 (€ 20,000) Unchanged	€ 150,000 Dividend 2025: € 150,000 ▲ 100% vs 2024 (€ 75,000) Unchanged	▲ 100%
Bank debt	€ 434,657 Bank debt 2022: € 434,657 First fiscal year in the series	€ 413,874 Bank debt 2023: € 413,874 ▼ 5% vs 2022 (€ 434,657) Favourable step	€ 392,713 Bank debt 2024: € 392,713 ▼ 5% vs 2023 (€ 413,874) Favourable step	€ 371,166 Bank debt 2025: € 371,166 ▼ 5% vs 2024 (€ 392,713) Favourable step	▼ 5%
Balance sheet total	€ 1,302,675 Balance sheet total 2022: € 1,302,675 First fiscal year in the series	€ 1,345,371 Balance sheet total 2023: € 1,345,371 ▲ 3% vs 2022 (€ 1,302,675) Unchanged	€ 1,438,344 Balance sheet total 2024: € 1,438,344 ▲ 7% vs 2023 (€ 1,345,371) Unchanged	€ 1,517,398 Balance sheet total 2025: € 1,517,398 ▲ 5% vs 2024 (€ 1,438,344) Unchanged	▲ 5%
Employees (FTE)	0.3 Employees (FTE) 2022: 0.3 First fiscal year in the series	1 Employees (FTE) 2023: 1 ▲ 0.7 vs 2022 (0.3) Unchanged	1 Employees (FTE) 2024: 1 Unchanged (1) Unchanged	1 Employees (FTE) 2025: 1 Unchanged (1) Unchanged

Key figures of APOTHEEK MEERDAAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK MEERDAAL?

What happened at APOTHEEK MEERDAAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 11, 2026 New annual accounts for financial year 2025: profit of € 171,332 (▲ 77% vs 2024). Source: NBB ↗
Feb 1, 1989 New establishment in Oud-Heverlee. KBO
Dec 30, 1988 Start of the company according to the CBE. KBO

In short

From € 104,425 profit in 2022 to € 171,332 profit in 2025.

Paid € 31,138 in corporate taxes since 2022.

Best year ever: 2025, with € 171,332 profit.

On average € 300,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Fré Pharma 100%

The stake of Fré Pharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK MEERDAAL

Behind APOTHEEK MEERDAAL is Fré Pharma BV. The shares are held by Fré Pharma (100%).

Directors

According to the 2025 annual accounts

Fré Pharma BV

Director · represented by Fréderic Hertens

Shareholders

Fré Pharma

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Bierbeekstraat 2B box 1

3052 Oud-Heverlee

2.041.888.996

Bierbeekstraat 1

3052 Oud-Heverlee

Active since 1 February 1989

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Dokter Marijke Vanderstappen

€ 192,434 gross margin · 2025

Fré Pharma same network

€ 78,271 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0436.782.387

VAT number

BE 0436.782.387

Registered office

Bierbeekstraat 2B bus 1, 3052 Oud-Heverlee

Names & denominations

APOTHEEK MEERDAAL

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

30 December 1988

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK MEERDAAL

Financials

What happened to APOTHEEK MEERDAAL?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions